Growth Metrics

DBV Technologies (DBVT) Cash & Equivalents (2014 - 2026)

DBV Technologies (DBVT) reported Cash & Equivalents of $229.2 million for Q1 2026, up 1668.25% year-over-year from $13.0 million in Q1 2025, and up 18.02% on a QoQ basis from $194.2 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Cash & Equivalents data on file, last reported at $229.2 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 1668.25% year-over-year to $229.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $229.2 million (up 1668.25% YoY) and the FY2025 annual result came in at $194.2 million, up 498.35% from the prior year.
  • Cash & Equivalents advanced to $229.2 million in Q1 2026 per DBVT's latest filing, from $194.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $248.0 million in Q2 2022 and bottomed at $13.0 million in Q1 2025.
  • The 5-year median for Cash & Equivalents is $141.4 million (2023), against an average of $132.7 million.
  • The widest annual swing landed in 2025, when Cash & Equivalents tumbled 87.23%; it then jumped 1668.25% in 2026.
  • Tracing DBVT's Cash & Equivalents over 5 years: stood at $209.2 million in 2022, then sank by 32.42% to $141.4 million in 2023, then slumped by 77.04% to $32.5 million in 2024, then surged by 498.35% to $194.2 million in 2025, then gained by 18.02% to $229.2 million in 2026.
  • Per Business Quant, the three latest DBVT Cash & Equivalents figures stand at $229.2 million (Q1 2026), $194.2 million (Q4 2025), and $69.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.91 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.71 Bn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 229.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 229.20 Mn
Dec 31, 2025 194.20 Mn
Sep 30, 2025 69.84 Mn
Jun 30, 2025 103.20 Mn
Mar 31, 2025 12.96 Mn
Dec 31, 2024 32.46 Mn
Sep 30, 2024 46.40 Mn
Jun 30, 2024 66.21 Mn
Mar 31, 2024 101.53 Mn
Dec 31, 2023 141.37 Mn
Sep 30, 2023 149.14 Mn
Jun 30, 2023 173.96 Mn
Mar 31, 2023 192.29 Mn
Dec 31, 2022 209.19 Mn
Sep 30, 2022 212.67 Mn
Jun 30, 2022 247.97 Mn
Mar 31, 2022 74.10 Mn
Dec 31, 2021 77.30 Mn
Sep 30, 2021 98.20 Mn
Jun 30, 2021 125.50 Mn
Mar 31, 2021 152.46 Mn
Dec 31, 2020 196.35 Mn
Sep 30, 2020 221.40 Mn
Jun 30, 2020 252.92 Mn
Mar 31, 2020 287.44 Mn
Dec 31, 2019 190.41 Mn
Sep 30, 2019 136.61 Mn
Jun 30, 2019 120.53 Mn
Dec 31, 2018 140.13 Mn
Sep 30, 2018 160.37 Mn
Jun 30, 2018 164.55 Mn
Dec 31, 2017 162.34 Mn
Jun 30, 2017 218.46 Mn
Dec 31, 2016 276.92 Mn
Jun 30, 2016 326.26 Mn
Dec 31, 2015 354.46 Mn
Jun 30, 2015 115.53 Mn
Dec 31, 2014 143.17 Mn